Specifically, the expression levels of the proinflammatory cytokines interleukin 1β (IL-1β) and interleukin 6 (IL-6) did not show any significant changes among the normal control healthy (NC), mild cognitive impairment (MCI) and dementia stage of AD patients (Table 2). This evidence concerns the gene IL1B and Alzheimer disease.